Description

A study by StrategyHelix indicates that the global digital therapeutics market is expected to increase by US$ 8.3 billion from 2022 to 2028, garnering a CAGR of 18.7% during the forecast period.

The report provides up-to-date market size data for period 2018-2021 and forecast to 2028 covering key market aspects like sales value for digital therapeutics. The global digital therapeutics market is segmented on the basis of application, end user, and region. Based on application, the global digital therapeutics market is categorized into cardiovascular diseases (CVD), central nervous system (CNS) diseases, diabetes, obesity, respiratory diseases, smoking cessation, others. On the basis of end user, the global digital therapeutics market has been segmented into employers, patients, payers, providers, others. In terms of geography, the global digital therapeutics market has been segmented into North America, Europe, Asia-Pacific, Rest of the World.

The global digital therapeutics market is highly competitive. The key players in the digital therapeutics market include 2Morrow Inc., Canary Health Inc., FITBIT Inc., NOOM INC., Omada Health Inc., Pear Therapeutics Inc., Propeller Health (ResMed Inc.), Teladoc Health Inc., TrialCard Incorporated, Twill Inc., Welldoc Inc.

The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the digital therapeutics market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

Report Scope

Application: cardiovascular diseases (CVD), central nervous system (CNS) diseases, diabetes, obesity, respiratory diseases, smoking cessation, others
End user: employers, patients, payers, providers, others
Region: North America, Europe, Asia-Pacific, Rest of the World
Years considered: this report covers the period 2018 to 2028

Key Benefits for Stakeholders

– Get a comprehensive picture of the global digital therapeutics market
– Pinpoint growth sectors and trends for investment

Table of Contents

Part 1. Introduction
– Scope of the study
– Study period
– Geographical scope
– Research methodology
Part 2. Digital therapeutics market overview
Part 3. Market breakdown by application
– Cardiovascular diseases (CVD)
– Central nervous system (CNS) diseases
– Diabetes
– Obesity
– Respiratory diseases
– Smoking cessation
– Others
Part 4. Market breakdown by end user
– Employers
– Patients
– Payers
– Providers
– Others
Part 5. Market breakdown by region
– North America
– Europe
– Asia-Pacific
– Rest of the World
Part 6. Key companies
– 2Morrow, Inc.
– Canary Health, Inc.
– FITBIT, Inc.
– NOOM, INC.
– Omada Health, Inc.
– Pear Therapeutics, Inc.
– Propeller Health (ResMed Inc.)
– Teladoc Health, Inc.
– TrialCard Incorporated
– Twill Inc.
– Welldoc, Inc.
About StrategyHelix
Disclaimer